NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pharma Holdings

Pharma Holdings

Private
OsloHealthcare & Life Scienceshttps://www.pharmaholdings.no/

Last Round

VC Round

Dec 22, 2023

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Pharma Holdings is a clinical-stage pharmaceutical company that develops antimicrobial drugs and treatments for respiratory viral infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antimicrobial drugvirtual biotechlytic peptidesclinical-stage pharmanasal decolonizationdrug licensingcontract research organizationCROcontract development and manufacturing organizationCDMOantibiotic alternativemembrane-lysingdrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pharma Holdings Comparables

Compare Pharma Holdings with similar companies based on industry and business-model similarity.

Pharma Holdings comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amprologix
86%
AMR Bio Limited
84%
EMV Capital
80%

Pharma Holdings Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 22, 2023
VC RoundDec 16, 2022
VC RoundFeb 3, 2021

Key People

Founding team and executive leadership

Chris Lütken

CEO

Executive Team

Torsteinn Erlingsson

CFO

Executive Team

Pharma Holdings Investors

Notable investors and investment history

Pharma Holdings investors
InvestorRounds
Picasso VenturesVC Round
AleapVC Round
Norinnova Forvaltning ASVC Round
NOMEVC Round, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 64% MoM, from 486 to 796.

  • Dec 16, 2022

    $2M raised from Norinnova Forvaltning AS and others.

Pharma Holdings Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pharma Holdings Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pharma Holdings's valuation, stock price, and market status.

Firmographic Details

HeadquartersOslo
Employee Range8
Year Founded2017
Last FundingDec 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.